The Transdermal Drugs Market growth at a CAGR of 5% & expected USD 9.60 billion by 2029. It is analyzed as product type, indication, distribution channel and end-user.

Oral Nonsteroidal Anti-Inflammatory Drugs Market was valued at USD 20,697.05 million in 2022, and it would grow to USD 32,641.01 billion, growing at around 5.86% by 2030

The Anti-Coccidial Drugs Market boost up with a CAGR of 9.2% & projected USD 3,103.95 million by 2030. It is divided into type, animals, distribution channel and end-user.

The Transdermal Drugs Market growth at a CAGR of 5% & expected USD 9.60 billion by 2029. It is analyzed as product type, indication, distribution channel and end-user.

The Janus kinases (JAKs) inhibitor drugs market worth was USD 2.45 billion in 2022 & it will surpass USD 5.11 billion by 2030 showing a CAGR of 9.6% by 2030.

The Psychedelic Drugs Market was valued at USD 2.71 billion in 2023 and is projected to reach USD 7.35 billion, with a CAGR of 13.3% by 2031

Global Purine Analogues Drugs Market, By Drug Type (Cladribine, Tioguanine, Clofarabine, Mercaptopurine, Fludarabine, Nelarabine, Others), End- Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Global PEGylated Drugs Market, By Molecule (Protein, FAB’ Fragment, Enzyme and Aptamer), Type (Interferons, Colony Stimulating Factors, Monoclonal Antibodies (mAbs), Other Types), Disease Indication (Gastrointestinal Disorders, Cancer, Multiple Sclerosis, Hepatitis, Other Disease Indications), Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), Sales Channel (Hospital Pharmacy, Online Provider, Retail Pharmacy), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

The Diuretic Drugs Market grow at a CAGR of 3.50% & expected to reach USD 1.20 billion by 2029. It is categorized by drugs class, route of administration, end user, distribution channel.